Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
369-386
Author(s):
G. Grassi, P. Dawson, G. Guarnieri, R. Kandolf and M. Grassi
Ribozymes in the Age of Molecular Therapeutics
Journal:
Current Molecular Medicine
Volume:
4
Page:
489-506
Author(s):
Sepideh Bagheri and Mohammed Kashani-Sabet
Therapeutic Antibodies
Journal:
Current Molecular Medicine
Volume:
4
Page:
539-547
Author(s):
Bernd Groner, Cord Hartmann and Winfried Wels
Creating Chemical Diversity to Target Protein Kinases
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
7
Page:
453-472
Author(s):
B. Li, Y. Liu, T. Uno and N. Gray
Corticotropin Releasing Factor (CRF) Peptide Family and their Receptors: Divergent Actions Influencing Human Physiology
Journal:
Current Genomics
Volume:
5
Page:
473-481
Author(s):
E. Karteris, H. S. Randeva and E. W. Hillhouse
DNA Methylation Leaves Its Mark in Head and Neck Squamous Cell Carcinomas (HNSCC)
Journal:
Current Genomics
Volume:
5
Page:
489-498
Author(s):
L. T. Smith and C. Plass
P-selectin Cell Adhesion Molecule in Inflammation, Thrombosis, Cancer Growth and Metastasis
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
2153-2160
Author(s):
Jian-Guo Geng, Ming Chen and Kuo-Chen Chou
COX-2 Selective Inhibitors, Carbonic Anhydrase Inhibition and Anticancer Properties of Sulfonamides Belonging to This Class of Pharmacological Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
625-632
Author(s):
Claudiu T. Supuran, Angela Casini, Antonio Mastrolorenzo and Andrea Scozzafava
A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2289-2298
Author(s):
Richard Piekarz and Susan Bates
Membrane Disrupting Lytic Peptides for Cancer Treatments
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2299-2310
Author(s):
Carola Leuschner and William Hansel